Systems Oncology

Systems Oncology

Biotechnology, 3955 Faber Pl Dr, Scottsdale, Arizona, 29405, United States, 11-50 Employees

systemsoncology.com

  • facebook
  • twitter
  • instagram
  • LinkedIn

phone no Phone Number: 14*********

Who is SYSTEMS ONCOLOGY

Systems Oncology is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and comba...

Read More

map
  • 3955 Faber Pl Dr, Scottsdale, Arizona, 29405, United States Headquarters: 3955 Faber Pl Dr, Scottsdale, Arizona, 29405, United States
  • 2015 Date Founded: 2015
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 4581

checked-icon Does something look wrong? Fix it. | View contact records from SYSTEMS ONCOLOGY

Systems Oncology Org Chart and Mapping

Employees

David Azorsa

Senior Vice President, Bioengineering

David Lee

Lab Manager/Sr. Researcher

Marvin Oketch

Associate Director, Immunobiology

Jeff Kiefer

Senior Vice President, Discovery Research

Katy Marhenke

Director of Business Development Operations

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Systems Oncology

Answer: Systems Oncology's headquarters are located at 3955 Faber Pl Dr, Scottsdale, Arizona, 29405, United States

Answer: Systems Oncology's phone number is 14*********

Answer: Systems Oncology's official website is https://systemsoncology.com

Answer: Systems Oncology's revenue is $25 Million to $50 Million

Answer: Systems Oncology's SIC: 4581

Answer: Systems Oncology has 11-50 employees

Answer: Systems Oncology is in Biotechnology

Answer: Systems Oncology contact info: Phone number: 14********* Website: https://systemsoncology.com

Answer: Systems Oncology is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance. Our Arromer platform is used to digitally engineer and rapidly produce self-delivering therapeutics which target specific tissues with unprecedented precision and accuracy. We are focused on building a pipeline of products in oncology, yet our multimodal RNA platform can be harnessed to transform outcomes for any complex polygenic disease.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access